References

Attele, A.S., Y.P. Zhou, J.T. Xie, J.A. Wu and L. Zhang et al., 2002. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes, 51: 1851-1858.
CrossRef  |  Direct Link  |  

Bravo, L., 1998. Polyphenols: Chemistry, dietary sources, metabolism and nutritional significance. Nutr. Rev., 56: 317-333.
CrossRef  |  PubMed  |  Direct Link  |  

Cemek, M., S. Kaga, N. Simsek, M.E. Buyukokuroglu and M. Konuk, 2008. Antihyperglycemic and antioxidative potential of Matricaria chamomilla L. in streptozotocin-induced diabetic rats. J. Nat. Med., 62: 284-293.
CrossRef  |  PubMed  |  Direct Link  |  

Cho, W.C.S., W.S. Chung, S.K. Lee, A.W. Leung, C.H. Chang and K.K. Yue, 2006. Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats. Eur. J. Pharmacol., 550: 173-179.
Direct Link  |  

Coskun, O., M. Kanter, A. Korkmaz and S. Oter, 2005. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and β-cell damage in rat pancreas. Pharmacol. Res., 51: 117-123.
CrossRef  |  PubMed  |  Direct Link  |  

Craig, W.J., 1999. Health-promoting properties of common herbs. Am. J. Clin. Nutr., 70: 491S-499S.
CrossRef  |  PubMed  |  Direct Link  |  

Crespy, V. and G. Williamson, 2004. A review of the health effects of green tea catechins in in vivo animal models. J. Nutr., 134: 3431S-3440S.
PubMed  |  Direct Link  |  

Dona, M., I. Dell Aica, F. Calabrese, R. Benelli, M.Morini, A. Albini and S. Garbisa, 2003. Neutrophil restraint by green tea: Inhibition of inflammation, associated angiogenesis and pulmonary fibrosis. J. Immunol., 170: 4335-4341.
Direct Link  |  

Evans, J.S., G.C. Gerritsen, K. Mann and S.P. Owen, 1965. Antitumor and hyperglycemic activity of streptozotocin (NSC-37917) and its cofactor, U-15, 774. Cancer Chemother. Rep., 48: 1-6.

Ihara, Y., S. Toyokuni, K. Uchida, H. Odaka and T. Tanaka et al., 1999. Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes, 48: 927-932.
CrossRef  |  Direct Link  |  

Kaneto, H., G. Xu, K.H. Song, K. Suzuma, S. Bonner-Weir, A. Sharma and G.C. Weir, 2001. Activation of the hexosamine pathway leads to deterioration of pancreatic β-cell function through the induction of oxidative stress. J. Biol. Chem., 276: 31099-31104.
CrossRef  |  Direct Link  |  

Kanter, M., H. Uysal, T. Karaca and H.O. Sagmanligil, 2006. Depression of glucose levels and partial restoration of pancreatic β-cell damage by melatonin in streptozotocin-induced diabetic rats. Arch. Toxicol., 80: 362-369.
CrossRef  |  Direct Link  |  

Kanter, M., O. Coskun, A. Korkmaz and S. Oter, 2004. Effects of Nigella sativa on oxidative stress and β-cell damage in streptozotocin-induced diabetic rats. Anat. Rec. Part A, 279: 658-691.
PubMed  |  

Katiyar, S.K., M.S. Matsui, C.A. Elmets and H. Mukhtar, 1999. Polyphenolic antioxidant (-) - epigallocatechin-3-gallate from green tea reduces UVB-induced inflammatory responses and infiltration of leukocytes in human skin. Photochem. Photobiol., 69: 148-148.

Kiefer, D. and T. Pantuso, 2003. Panax ginseng. Am. Fam. Physician, 68: 1539-1542.
PubMed  |  Direct Link  |  

Manna, P., M. Sinha and P.C. Sil, 2009. Protective role of arjunolic acid in response to streptozotocin-induced type-I diabetes via the mitochondrial dependent and independent pathways. Toxicology, 257: 53-63.

Miyazaki, T., 1989. Chemical Structure and Biological Activity of Polysaccharides. Asakura Publishing House, Tokyo, Japan, pp: 138-181.

Nogichi, H., 2007. Stem cells for the treatment of diabetes. Endocr. J., 54: 7-16.

Olajide, A.O., A.S. Awe, J.M. Makinde and O. Morebise, 1999. Evaluation of the anti-diabetic property of Morinda lucida leaves in streptozotocin diabetic rats. J. Pharm. Pharmacol., 51: 41-46.

Pushparaj, P., C.H. Tan and B.K.H. Tan, 2000. Effects of Averrhoa bilimbi leaf extract on blood glucose and lipids in streptozotocin-diabetic rats. J. Ethnopharmacol., 72: 69-76.
CrossRef  |  PubMed  |  Direct Link  |  

Rakieten, N., M.L. Rakieten and M.V. Nadkarni, 1963. Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother. Rep., 29: 91-98.
PubMed  |  

Ryu, O.H., J. Lee, K. Lee, H. Kim and J. Seo et al., 2006. Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Diabetes Res. Clin. Pract., 71: 356-358.
Direct Link  |  

Saravanan, G., L. Pari and S. Venkatesvaran, 2002. Effect of cogent db, a herbal drug, on plasma insulin and hepatic enzymes of glucose metabolism in experimental diabetes. Diab. Obes. Metabol., 4: 1-5.

Sato, T. and G. Miyata, 2000. The nutraceutical benefit, Part I: Green tea. Nutrition, 16: 315-317.

Szkudelski, T., 2001. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol. Res., 50: 537-546.
PubMed  |  Direct Link  |  

Tiedge, M., S. Lortz, J. Drinkgern and S. Lenzen, 1997. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes, 46: 1733-1742.
CrossRef  |  Direct Link  |  

Vuksan, V., J.L. Sievenpiper, J. Wong, Z. Xu and U. Beljan-Zdravkovic et al., 2001. American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dosedependent manner in healthy individuals. Am. J. Clin. Nutr., 73: 753-758.
Direct Link  |  

Wang, B.X., Q.L. Zhou, M. Yang, W. Yan, C. Zhi-Yong, L. Yong- Qiang and I. Takashi, 2003. Hypoglycemic activity of ginseng glycopeptide. Acta Pharmacol. Sin., 24: 50-54.
Direct Link  |  

Wesnes, K.A., T. Ward, A. McGinty and O. Petrini, 2000. The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology, 152: 353-361.

Xie, J.T., C.Z. Wang, S. Kim and Yuan, 2005. The anti-hyperglycemic property of different ginseng partitions. Orient Pharm. Exp. Med., 5: 1-15.

Yang, M., B.X. Wang, Y.L. Jin, Y. Wang and N.Y. Cui, 1990. Effects of ginseng polysaccharides on reducing blood glucose and liver glycogen. Acta Pharmacol. Sin., 11: 520-524.
Direct Link  |